J Pharmacol Exp Ther 289, 321-328, (1999a). Soriani, O., Foll, F. L., Roman, F., Monnet, F. P., Vaudry, H., & Cazin, L. View abstract in PubMed Post navigationPreviousPrevious post:Olfactory bulbectomy increases prepro-enkephalin mRNA levels in the ventral striatum in rats.NextNext post:Binding of dimemorfan to sigma-1 receptor and its anticonvulsant and locomotor effects in mice, compared with dextromethorphan and dextrorphan.Related PostsAnavex Life Sciences to Present at the 30th Annual ROTH ConferenceMarch 9, 2018Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018Anavex Life Sciences to Present at Cowen and Company 38th Annual Health Care ConferenceMarch 6, 2018Anavex Life Sciences Strengthens Management Team and Board of DirectorsMarch 5, 2018
Anavex Life Sciences to Present New Preclinical Data at the 20th Annual Meeting of the American Society for Experimental Neurotherapeutics (ASENT)March 7, 2018
